[Cancer Management and Research] Chinese researchers present a review of a rare cancer and strategies for managing the most common adverse effect of its treatment.
Researchers outline best practice for responding to anticancer therapy-induced hypersensitivity.
A review of outcomes in the MAVORIC trial for patients with CTCL who experienced treatment-related AEs.
Including chlorhexidine gluconate-impregnated dressing in central line bundle resulted in a dramatic change in central line infections.
Patient-completed pill and toxicity diaries were linked to medication adherence and timely management of AEs in clinical trial participants.
A multidisciplinary program developed to educate nurses on recognizing and managing the signs and symptoms of CAR-T cell therapy adverse effects.
Investigators sought to determine if electronic patient-reported outcome tools with the PROMIS network improved identifying patients with severe symptoms and increased referrals to ancillary support services.
University of Michigan researchers explored the potential of self-acupressure to help women with breast cancer better manage symptoms such as fatigue, pain, and depression.
Most patients undergoing anticancer chemotherapy or radiation therapy will experience treatment-induced nausea and vomiting. But key gaps remain in our understanding of how best to prevent and treat this debilitating adverse effect, leading to inconsistencies among clinical antiemetic guidelines. The available evidence for how best to prevent and manage nausea and vomiting during and following…
[Cancer Management and Research] Researchers report on the efficacy of palliative CSI in alleviating neurologic symptoms or delaying neurologic deterioration in patients with leptomeningeal carcinomatosis.
